Zenabis gelcaps recalled in New Brunswick after CBD is mislabelled as THC

4y
2m read
Summary

Neither Zenabis nor the regulator have received any reports of adverse reactions or issues related to the mislabelled capsules. While both THC and CBD are psychoactive, only THC is intoxicating. “These units contain the incorrect cannabis product,” notes the recall notice. “The label indicates that the product is ‘CBD Light gelcaps’. Stores “Namaste CBD Light gelcaps” from LP Zenabis actually contained THC (aka tetrahydrocannabinol) instead of CBD (cannabidiol). Health Canada has issued a recall for more than 700 bottles of mislabelled cannabis oil gel capsules in New Brunswick. The recalled lot was sold to Cannabis NB this past Oct. 7, and 768 units of recalled product have been sold.

Article Preview

Health Canada has issued a recall for more than 700 bottles of mislabelled cannabis oil gel capsules in New Brunswick.

Quebec’s provincial retailer, HEXO issue consumer product recall of mislabelled cannabis flower Irish product recall issued following discovery of...

Read the full article @ The Growth Op